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Diabeticretinopathyistheleadingcauseofvisuallossinindividualsundertheageof55.Umbilicalcordblood
(UCB)–derived myeloid progenitor cells have been shown to decrease neuronal damage associated with
ischemia in the central nervous system. In this study we show that UCB-derived CD14
1 progenitor cells
providerescueeffectsinamousemodelofischemicretinopathybypromotingphysiologicalangiogenesisand
reducing associated inflammation. We use confocal microscopy to trace the fate of injected human
UCB-derived CD14
1 cells and PCR with species-specific probes to investigate their gene expression profile
before and after injection. Metabolomic analysis measures changes induced by CD14
1 cells. Our results
demonstrate that human cells differentiate in vivo into M2 macrophages and induce the polarization of
resident M2 macrophages. This leads to stabilization of the ischemia-injured retinal vasculature by
modulating the inflammatory response, reducing oxidative stress and apoptosis and promoting tissue repair.
I
schemicdamageisthemajorcauseofneuronaldeathinthecentralnervoussystemleadingtosignificantlossof
function in millions of individuals each year. As a direct extension of the central nervous system, the retina
suffers many of the same hypoxic injuries. Ischemic retinopathies such as those associated with diabetes and
prematurity are the leading causes of visual loss in individuals under the age of 55 and neonates, respectively.
Vision loss in these individuals occurs as a result of abnormalities in the retinal vasculature, leading to retinal
edema, hemorrhage, gliosis (scarring) and/or neovascularization and, in some cases, tractional retinal detach-
ments and blindness. Therapeutic interventions focus on eliminating the vascular abnormalities through the use
of lasers or angiostatic drugs injected intravitreally. While dramatic effects can be achieved in select groups of
patients, most experience disease progression and associated vision loss.
Stemandprogenitorcellshavebeenisolatedfrombonemarrow(BM),peripheralorhumanumbilicalcordblood
(hUCB)asaninnovativetherapyfortreatmentofischemicandneuro-degenerativeretinopathies.Theutilityofsuch
a treatmentcomesfromthe abilityofstem/progenitorcells todifferentiateintomaturecellsand torepair damaged
tissue and/or provide direct, paracrinerescueeffects.Thesecellsand their differentiatedprogenies may alsorecruit
endogenous and circulating cells to areas of damaged tissue, contributing to the rescue effect.
UCB is a rich source of hematopoietic stem cells (HSCs) including high numbers of early and late myeloid
progenitor cells
1. Compared to adult BM and peripheral blood, UCB-derived progenitor cells exhibit increased
capacity to proliferate and subsequently differentiate into colony forming unit-granulocyte macrophages (CFU-
GM)
2. In addition, UCB-derived cells are less mature relative to adult stem cells; they have not been exposed to
immunologic challenge and are unable to activate cytotoxic T-lymphocytes to synthesize pro-inflammatory
cytokines
3.
Reports from several groups have shown that local transplantation or intravenously injected UCB-derived
mononuclear cells improves functionality in areas of ischemia
1,4 This rescue function is associated with the
CD14
1 monocyte fraction since depletion of these cells from the UCB led to loss of the rescue function in a
rat model of middle cerebral artery occlusion
5. In vitro, the UCB-derived CD14
1 cells can differentiate into
endothelial
6,7, neuronal
8,9 and mature myeloid (e.g., monocytes, macrophages and dendritic) cells. UCB-derived
neural progenitors have also been observed to be neuroprotective in an in vitro model of ischemia
10. Recent
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loidcellstomultiplestimuliinfluencingtheirfateintopro-,andanti-
inflammatory macrophages (M1 and M2, respectively), endothelial,
ordendriticcells
11–15.Thus,differentsubpopulationsofmyeloidcells
couldexertoppositeeffectsduringangiogenesis;onepopulationmay
contribute to plaque formation in experimental models of arterial
occlusion
16whereanothermaypromotecollateralgrowthtoalleviate
ischemia
17. The retina provides a good model system in which to
study these discordant results; tissue-resident and recruited macro-
phagepopulationshavebeenimplicatedinbothdevelopmental
18and
pathologic angiogenesis
19, processes that may occur simultaneously
in the same tissue during response to ischemic injury.
A recent study
20 has examined the role of macrophages in the
establishment of vascular networks. These cells act as ‘‘bridge cells’’
byestablishing tip-cellanastomosis andreleasing angiogenic factors,
such as VEGF, that can lead to vessel fusion and vascular network
formation.Previous studiesofthe samecellshave demonstrated that
tumoursordeveloping/regeneratingtissuescanactivelyrecruitthese
cells from the circulation
21.
InourstudywehaveusedhUCBtoobtainanenrichedpopulation
ofmyeloidprogenitorcells,CD14
1cells,whichwheninjectedineyes
of mice with oxygen-induced retinopathy (OIR), exerted a profound
rescue effect. Only CD14
1 cells polarized to M2 macrophages were
abletocontrolthepathologicalneovascularization.Inordertobetter
understand the molecular events that regulate the observed rescue
effect we: (i); studied the fate of the CD14
1 in the retina; (ii) quan-
tified the level of gene expression of injected hUCB-derived CD14
1
cells before and after rescue using transcriptomic analysis with
human specific primer probes; and (iii) studied the metabolic
deregulation occurring in the retinas of OIR mice by mass spectro-
metry-basedmetabolomicsbeforeandafterinjectionofCD14
1cells.
Fromthesestudies weconcludethat hUCBCD14
1cells differentiate
in vivo into type 2 macrophages and initiate a series of events associ-
ated with modulation of the inflammatory response leading to
reduced oxidative stress and apoptosis and, ultimately, promoting
normal angiogenesis and tissue repair in the retina.
Our ability to directly image and follow the fate of human mono-
cytes in vivo, together with the use of cell/tissue-specific transcrip-
tomic and metabolomic analysis of these cells and their target tissue
provide novel insights into the behaviour of monocyte/macrophage
cellular subsets during angiogenesis and inflammation.
Results
Human umbilical cord blood-derived CD14
1 cells stabilize
ischemia-injured vasculature in the retina. In the mouse OIR
model, a transient period of hyperoxia during retinal vascular
development attenuates normal retinal vessel development and
leads to degeneration of the newly formed, immature vasculature.
Upon return to normoxia, the central retinal area where the
vasculature has regressed becomes hypoxic leading to development
of pathological neovascularization (NV) at the interface between
perfused and non-perfused retina
22. In this model, the retinal
vasculature of both BALB/cByJ and C57BL/6J strains of mice
becomes obliterated to a similar extent. However, in retinas from
BALB/cByJ mice, the vaso-obliterated regions revascularize more
rapidly and pathological, pre-laminar neovascular tufts do not
form. In contrast, the retinas of pigmented C57BL/6J mice are
characterized by slower revascularization of the central retina and
thereisextensiveformationofpathological,pre-laminarneovascular
tufts (Supplementary Fig 1A).
We alsohypothesized retinas in the BALB/cByJ strain is protected
fromneovascularization byamore rapidrecruitment of endogenous
anti-inflammatory microglia during the hypoxic phase of the OIR
model (unpublished observations).
Freshly isolated CD14
1 cells derived from hUCB consist of a
heterogeneous population of myeloid cells. The CD14
1 cells were
injected intravitreally at postnatal day 7 (P7) in C57BL/6J pups and
themiceweremaintainedinanatmosphereof75%oxygenfor5days
(P7–P12) to induce the ischemic retinopathy. At P17, vaso-oblitera-
tion and neovascularization were reduced by 63% and 56%, respect-
ively, in retinas treated with CD14
1 cell grafts compared to retinas
treatedwiththevehicleDPBS(Fig1A,B).Nosignificantrescueeffect
was observed when CD14
2 cells were used (Fig 1B).
Next,CD14
1cellsweretransducedwithanadenoviralvector(Ad5
F16)encodingenhanced-green fluorescentprotein(eGFP)
25toassist
in visualizing the cell transplants. The eGFP-labelled CD14
1 cells
were observed to target the retinal vessels from P12 and to be prim-
arilylocalizedaroundtheretinalvasculature10daysafterintravitreal
injection (P17). CD14
1 cells targeted the vessels showing highly
arborizing processes with a macrophage cell-like shape. EGFP
1 cells
wrapped around vessels for long distances and when targeting the
neovascularization areas maintained a round morphology as fresh
isolated from the cord blood (Fig 1C, D, E). Using 3D image recon-
struction, we confirmed that the CD14
1 cells were localized to the
vascularsurfaceandnotintegratedintothevesselitself.Importantly,
intravitreal injection of CD14
1 cells infected with Ad5F16-eGFP did
not reduce the rescue function observed with a non-Ad5F16-eGFP
infected CD14
1 cells, indicating that transduction of the cells with
theAdvectordoesnotsignificantlyimpactrescue.Fromtheseobser-
vations we conclude that hUCB-derived CD14
1 cells differentiate
in vivo into a myeloid cell with dendritic-macrophage cell-like mor-
phology,exert trophic rescue effects inthe mouse OIR model and do
so by adhering to, and wrapping around, the retinal vasculature
rather than integrating into it. This rescue effect and differentiation
is not an immunological response associated with the injection of
human cord blood cells into the mouse eye (xenotransplant); the
rescue and differentiation effects were not observed with the injec-
tion of human CD14
2 cells into the mouse eye (Figure 1B). Next, we
conducted a molecular characterization of injected cells and retinal
tissueinorder tobetterunderstand the mechanism bywhichCD14
1
cells promote normalization of retinal vasculature and tissue repair.
hUCB-derived CD14
1 cells reduce level of ischemia and stimulate
the recruitment of endogenous myeloid cells. Injection of CD14
1
cells significantly reduced the area of vaso-obliteration, thus limiting
retinal vascular damage and enhancing tissue repair during the
period of hyperoxia (P7–P12). We observed a 50% reduction of
obliterated area at P12 (one day after returning to normoxia)
(Fig 2A) and significant recruitment of lectin positive cells such as
leukocytes and EPCs from the peripheral blood when we injected
CD14
1cells compared to vehicle injection (Fig 2B, C,D). These cells
have been demonstrated to be fundamental not only for an ischemic
tissue repair but also for the stabilization of retinal vasculature
26.I ti s
importanttonotethatinanormoxic environmentatP12,formation
of the superficial retinal vascular plexus is already complete but the
deep and intermediate vasculature is still forming through P21.
CD14
1 cells, by contributing to the recruitment of angiogenic cells,
maintain vascular growth in the deep plexuses and prevent
neovascularization formation at P17.
Next, we undertook a human specific transcriptomic analysis of
P17 mouse retinas with the injection of hUCB CD14
1 and CD14
2
cells to define the differentiation state of the human cells and the
mechanism of action contributing to their rescue of OIR retinas
during hypoxia.
Cord blood-derived CD14
1 cells express mRNAs associated with
the oxidative stress response, cell cycle, and macrophage cell
markers. The molecular changes associated with stabilization of
retinal vasculature by hUCB-derived CD14
1 cells were assessed at
the mRNA level by selectively detecting and quantifying the
expression level of 50 human genes in the mouse retina. Specifically,
wemeasured the expressionratio ofhuman genesinthe mouse retina
atP17afterintravitrealinjectionatP7ofCD14
1,CD 14
2cells(control
www.nature.com/scientificreports
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analysis of retinas treated with CD14
1 cells revealed increased
expression of human antigens of M2 macrophages. The molecule
CD14 and other monocytic cell markers such as CD163
27,C D 6 8
28,
CD209
29 and HLA-DRA
30 were highly upregulated after the injection
of CD14
1 relative to CD14
2 (CD14
1/CD14
2 .1.6). Importantly, we
also detected increased expression of human genes (CD14
1/CD14
2
.1.6) associated with the oxidative stress response including SOD1,
encodingsuperoxidedismutase1.Interestingly,infreshlyisolatedcells
(day 0) SOD1 expression was higher in CD14
2 population compared
to CD14
1 cells (Supplementary Fig 2). Additional oxidative stress-
associated genes were also detected including human CAT, GPX1,
HMOX1 and ALDOA.
TheCD14
1cellsalsoinducedexpressionofgenes(CD14
1/CD14
2
.1.6)involvedincellsignalingsuchasIFI16
31,IFI6,BCL2A1,AKT1
and NF-kB1. TGFb1, expressed by the leukocyte lineage to control
cell differentiation, proliferation, and resolution of inflammation,
wasalsohighlyupregulatedinthemouseretinaatP17afterinjection
of CD14
1 cells. The transcription factor STAT3, responsible for
controlling anti-inflammatory pathways
32,33, was up regulated by
CD14
1 cells compared to the negative fraction. We also observed
that TNF, a cytokine responsible for the recruitment of pro inflam-
matory leukocytes, was not expressed by CD14
1 cells and is, in fact,
slightly down regulated compared to the negative fraction.
Genes associated with cell adhesion such as ICAM-1 (also known
asCD54),humanCD44andITGAMwerealsohighlyexpressedafter
injection of CD14
1 cells relative to CD14
2 and vehicle. Other genes
withdiversebiologicalroleswerealsoupregulatedbytheintravitreal
injection of hUCB-derived CD14
1 cells relative to the CD14
2 frac-
tion and vehicle: (i) human CCR5, encoding CCchemokine receptor
Figure 1 | CD14
1 cells stabilize and promote normalization of ischemia-injured retinal vasculature in the OIR model. A) CD14
1 cells normalize
angiogenesis during hyperoxia and accelerate retinal revascularization. Normal retinas were dissected from C57BL/6J mice and stained with GS lectin at
postnatal day 17 (P17). They show a characteristic branching vascular pattern radiating outward from the central optic nerve head (‘‘Control
Normoxia’’).Exposuretohyperoxiafor5days(fromP7toP12)leadstocentralvaso-obliteration.Oncethemicereturntonormoxia,neovascularisation
occurs at the interface between perfused peripheral, andnon-perfused central, retina. Treatment withvehicle (‘‘Vehicle treated’’) at P7 does not alter the
vaso-obliteration or neovascularisation. In contrast, treatment at P7 with hUCB-derived CD14
1 cells leads to normalization of the retinal vasculature
(‘‘CD14
1 treated’’). B) Quantification of retinas treated with hUCB-derived cell populations. Retinas were analyzed at P17 using GS-lectin staining for
retinalvesselobliteration(yellowbars)andtuftformation(neovascularization)(redbars)inretinalwholemounts.Nosignificantdifferencewasobserved
between vehicle and CD14
2 cells when injected intravitreally at P7. Obliteration and neovascularization are reduced by 63% and 56% respectively,
compared to vehicle-treated retinas (n557, n540, n570, n5number of eyes) (*P ,0.001 Bonferroni corrected t-test). C) D) And E) Ad5F16-eGFP
hUCB-derived CD14
1 cells (green) target and differentiate along the mouse retina vasculature (red) at P17 (10x, 20x and 40X respectively).
www.nature.com/scientificreports
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ritic cells and microglia that binds cytokines as MIP-1alpha and beta
and Rantes; (ii) ALDOA, encoding aldolase A; (iii) HIF1A, hypoxia-
induciblefactor1-alpha;(iv)GUSB,encodingb-glucuronidase;and(v)
SERPINA 1 (also alpha-1-antitrypsin), encoding a serine proteinase
inhibitor that protects tissues from enzymes of inflammatory cells
such as elastase. Interestingly, the tissue inhibitor metalloproteinase
1(TIMP1),knowntoinhibittheactivityofMMP1andMMP13andso
to block angiogenesis in vivo and in vitro
34 was up regulated by the
positive fraction compared to the negative population.
Overall, the transcriptomic data supports our initial histological
and antibody array results indicating that CD14
1 differentiates into
a macrophage polarized M2 type and exerts rescue effects in
associationwiththeexpressionofgenesthatregulateoxidativestress,
apoptosis and control of inflammation and angiogenesis.
HUCB-derived CD14
1 cells reduce the levels of oxysterols in OIR
retinas, resembling the response of BALB/cByJ mice to hypoxia.
Severe levels of oxidative stress can damage all components of the
cell, including metabolic intermediates such lipids (i.e., lipid
peroxidation). Therefore, we performed a metabolomic analysis
using mass spectrometry in order to investigate whether the rescue
effects of the CD14
1 cells are partially explained by their capacity to
suppress metabolic oxidative damage in retinal tissue.
We analyzed retinas of C57BL/6J mice at P12 as the first stage
between the hyperoxia and hypoxia, P15 as middle hypoxia and P18
Figure 2 | CD14
1 cells promote angiogenesis and recruit endogenous proangiogenic cells in hypoxic areas (A) At P12 the obliteration area in CD14
1
treated eyes is reduced by 50% compared to vehicle-treated retinas (n58, n5number of eyes for each condition). (B) Lectin-positive cells in areas of
vaso-obliteration are increased 2.2- fold after intravitreal injection of CD14
1 cells relative to vehicle injection (n56, n5number of eyes for each
condition)(*P,0.001Bonferronicorrectedt-test).(C)10xconfocalimagesofretinastreatedwithCD14
1showshighrecruitmentoflectin-positivecells
with microglial-like morphology. (D) Lectin-positive cells are absent in vehicle-injected retinas.
www.nature.com/scientificreports
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1 cells regulate oxidative stress and apoptosis, and express markers of myeloid cell differentiation in the OIR
model. Several human genes are up-regulated at P17 in the CD14
1-treated retinas compared to retinas injected with the negative fraction, CD14
2cells
and compared to retinas injected with the vehicle, DPBS. A fold increase of 1.6 or greater of anti-apoptotic genes is observed (black) (IFI6, IFI16, AKT1,
BCL2A1). Human anti-oxidative stress genes are significantly up regulated when CD14
1 cells are injected compared to the negative fraction (green).
Numerous genes characteristic of myeloid cell differentiation are highly expressed in the CD14
1-treated retinas (blue). The CD14
1 cells increase
expression of vascular adhesion molecules (ICAM1) and the extracellular matrix receptor (CD44) (orange). Genes characteristic of endothelial cell
differentiation (VEGF) and inflammation (TNF, IL6) are not significantly different between the CD14
1 cells and the retinas treated with the negative
fraction. (n512, n5number of retinas independently extracted and analyzed for each treatment) (*P ,0.01; **P ,0.001).
www.nature.com/scientificreports
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moxia and OIR, and between retinas treated with CD14
1 cells and
vehicle. Untargeted metabolomic analysis (Fig 4) revealed only
minor changes between normoxia and OIR at P12, indicating that
hyperoxia does not significantly affect the metabolome in the
developing retina. By P15, (after 3 days of induced-hypoxic condi-
tions) only ,4% of the metabolites detected were up regulated (.2
fold; P ,0.01) in OIR retinas relative to normoxia. However, after
6 days under hypoxic conditions (P18), and coinciding with the
observed histopathological changes (i.e. neovascular tufts) observed
in the OIR model, approximately 15% of the metabolites detected in
OIR retinas were differentially regulated (.2-fold, P ,0.01) relative
to normoxia. In contrast, when the retinas were treated with CD14
1
cells at P7, only ,2% of the metabolites remained deregulated
(.2-fold, P ,0.01) at P18 (Fig 4). We used tandem mass spectro-
metry (i.e. ESI-Q-TOF MS) to identify of some of the metabolites
deregulated at P18 under OIR conditions whose levels were normal-
ized by intravitreal injection of CD14
1 cells. The deregulated
metabolites included oxysterols such as 5,6b-epoxy-cholesterol,
7-ketocholesterol, and 7a-hydroxycholesterol (Table 1). Oxysterols
are oxidation products of cholesterol that exert cytotoxic, pro-oxid-
ant and pro-inflammatory effects in vivo
35–38. We also observed the
accumulation of several acyl-carnitine structures at P18 in OIR ret-
inas. Acyl-carnitines are fatty acyl-CoA (coenzyme A) conjugated to
carnitine and assist with the transport and metabolism of fatty
acids into mitochondria, where they are undergo b-oxidation.
Importantly, 11-cis-retinal was identified as one of the few metabo-
lites whose abundance decreased at P18 in the OIR model. The
metabolite 11-cis-retinal is an endogenous chromophore bound to
opsin; its photoisomerization is the chemical basis for vertebrate
vision. The level of oxysterols (Supplementary Fig 3A,B,C) and
11-cis-retinal (Supplementary Fig 3D) was completely normalized
at P18 by the treatment with CD14
1 cells and the level of acyl-carni-
tines was significantly reduced (,2-fold) compared to the non-
treated retinas (5–9 fold) (Table 1).
Previous studies have shown that BALB/cByJ mice placed into the
OIRmodeldonotformtuftstoanappreciabledegreeandthecentral
vaso-obliterationarearevascularizesquicklyfollowingreturntonor-
moxia
26. When untreated, wild type BALB/cByJ mouse retinas were
analyzedatP18undertheOIRconditionsusingthesameuntargeted
massspectrometry-basedmetabolomicapproach,weobservedaglo-
bal trend similar to that observed in C57BL/6J mice treated with
CD14
1 cells under OIR conditions (Fig 4). Essentially, only ,1.7%
of the metabolites detected in BALB/cByJ retinas appeared up regu-
lated (. 2-fold, P ,0.01) at P18 relative to normoxia. It is of interest
to note, however, that both BALB/cByJ and C57BL/6J mice treated
withCD14
1cells showed amarkedly highpercentage ofdown-regu-
lated metabolites relative to normoxia at P18.
Overall,themetabolomicdatarevealsthatoxidativedamageinthe
retina does not occur during the period of hyperoxia, but does so as
the result of the oxygen/reperfusion injury following the induced-
hypoxia. Importantly, our results also demonstrate that intravitreal
injection of CD14
1 cells reduces the metabolic oxidative damage by
controlling the production of oxysterols.
5,6b-epoxy-cholesterol and 7-ketocholesterol induce astrocyte
disorganization, gliosis, and apoptosis by activating caspase 3.
Having observed a high expression level of genes that regulate
apoptosis in retinas treated with CD14
1 cells, we studied the role
of oxidized forms of cholesterol in the pathogenesis of retinal tissue.
Initially, astrocytes and endothelial cells, two different cell types
found in the retina, were cultured in vitro and treated with the
identified oxysterols in a dose-dependent manner. Cultured mouse
astrocytes exhibited a dose-dependent toxicity response after
treatment with increasing concentrations of b-epoxy-, 7a-
hydroxy-, and 7-ketocholesterol (Supplementary Fig 4A). At the
highest dose tested, 0% (P ,0.001) and 4.8 6 4.5% (P ,0.001) of
the astrocytes were viable after treatment with 7-keto- and
b-epoxycholesterol, respectively, compared to 80 6 4.5% viability
in the astrocyte culture treated with vehicle (i.e., regular media and
Figure 4 | Global metabolomic analysis of the OIR model. Bars indicate
the percentage of up-regulated or down-regulated mass spectrometry
features (*P ,0.01) in the OIR retinas relative to normoxia at post natal
day 12, 15 and 18. Results correspond to C57BL/6J mouse strain unless
otherwise stated. 8–12 independently extracted retinal tissues were
analyzed for each time point or treatment, n58–12).
Table 1 | Fold change of oxysterols, carnitines and 11-cis retinal in OIR retinas compared to Normoxia
C57BL/6J (P18) BALB/cByJ (P18)
Metabolite
OIR/Normoxia OIR1CD14
1/ Normoxia OIR/Normoxia
Fold P value Fold P value Fold P value
7-ketocholesterol 6.7 2.3310
26 1.3 0.2 1 0.67
5,6b-epoxy-cholesterol 5.1 2.1310
26 1.4 0.37 1.1 0.78
7a-hydroxycholesterol 3.9 5.8310
26 1 0.91 1 0.68
11-cis-retinal 0.3 5.6310
25 0.83 0.047 n.d n.d
Decanoylcarnitine 5.7 9.0310
28 2 0.002 2.4 4.2x10
26
Octanoylcarnitine 5.5 5.5310
24 2.2 9.58310
25 1.8 5.4x10
25
Laurylcarnitine 9.1 2.9310
27 2.6 7.8310
24 2 1.0x10
25
Tetradecenoylcarnitine 8.8 7.5310
29 2.1 1.1310
24 1.2 0.02
Hexadecenoyl carnitine 5 3.1310
29 1.3 0.032 0.6 0.016
Tetradecanoylcarnitine 7.2 5.9310
29 2 2.9310
24 1.4 0.0013
www.nature.com/scientificreports
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hydroxycholesterol, cell viability was 63.1 6 3.9% (P . 0.05).
Alternatively, when cultured human vascular endothelial cells
(HUVEC) were exposed overnight to 40 mg/ml of 5,6b-epoxy-
cholesterol, only 4.6% of the cells remained viable (P ,0.001)
(Supplementary Fig 4C). The alpha isomer (5,6a-epoxy-
cholesterol), however, maintained HUVEC viability close to 60%
(data not shown), indicating the functional specificity of this
metabolite. HUVEC were exposed to hydrogen peroxide (H2O2)a s
a positive control of cellular toxicity (Supplementary Fig 4C).
To better understand the mechanism by which these oxidized
forms of cholesterol were toxic, we studied the cleavage of caspase-
3, a marker of apoptosis. Using Western blot analysis, we observed
activation of caspase-3 in cell cultures of bovine aortic endothelial
cells (Fig 5A) or mouse astrocytes (Fig 5B) treated with 5,6b-epoxy-,
7-keto-, and 7a-hydroxycholesterol. This is consistent with the
Figure 5 | Oxysterols induce apoptosis in endothelial cells and astrocytes in vitro. Western Blot analysis shows the cleavage of Caspase-3 induced by
b2epoxycholesteroland7-ketocholesterolinBovineAorticEndothelialcells(A)andC8-D1Aastrocytes(B).Staurosporin(ST)wasusedaspositivecontrol.
Actin level is reported to normalize the quantity of protein in each sample (n53, n5number of experiments) (Bonferroni corrected t-test: *P ,0.01).
www.nature.com/scientificreports
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from mice under OIR conditions. We observed an increase of 65%
and 130% of caspase-3 cleavage in OIR retinas at P15 and P18,
respectively, relative to normal developing retinas (Supplementary
Fig 5). No observable difference in caspase-3 cleavage was observed
at P12 between normal and OIR retinas (data not shown).
Themorphologicaleffectofintravitreallyinjectingb-epoxy-,and7-
ketocholesterolintoP15miceundernormaldevelopingconditions(i.e.
normoxia)wasevaluated3dayslateraftertreatment(P18).Compared
tocontroleyes(Fig6A,a),retinasinjectedwith5,6b-epoxy-(Fig6B,b)
or 7-ketocholesterol (Fig 6C, c) showed disruption of the astrocytes
associated with the superficial retinal vascular plexus and a strong
Figure 6 | Oxysterols are toxic for astrocytes and muller glia cells in vivo. Immunohistochemical analysis using lectin (red, blood vessels) and antibody
toGFAP(green,astrocytesandactivated Mullergliacells)demonstratesthenormalretina(A)orabnormalities observed withdegeneration ofastrocytes
inthe inner retinaafter intravitreal injection of b-epoxy-cholesterol (B) or 7-ketocholesterol (C). Insets inA, Band C represent 20Xmagnification views
of GFAP expression. Inset figures a, b, c show 20X magnification views of whole mount retinas from the same specimen; astrocytes (green) appear
damagedand the muller gliacells (green dots)are visible inthe superficial plexus ofthe vasculature (red) demonstrating severe gliosis (n55,n5number
of eyes for each treatment). HUCB derived CD14
1 cells prevent Muller Glia cells activation in OIR retinas. Immunohistochemical analysis using an
antibody to GFAP demonstrates degeneration of astrocytes layer and gliosis (red arrows) in P17 OIR retinas (D). Treatment with HUCB CD14
1 cells
prevents this damage (E) (n56, n5number eyes for each condition).
www.nature.com/scientificreports
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OIR mice (not exposed to exogenous 5,6 b-epoxy-, and 7-ketocholes-
terol) showed reactive gliosis of the muller glia cells at P18 (Fig 6D).
The treatment of OIR retinas with CD14
1 cells prevented disorgan-
ization of the astrocytic layer and reactive gliosis (Fig 6E).
Overall, our results indicate that accumulation of b-epoxy- and
7-ketocholesterol metabolites in the OIR retinas induces apoptosis
by activation of caspase-3 cleavage, leading to a disruption of the
astrocyte organization and gliosis of the Muller glia cells in the outer
layer. Treatment with CD14
1 cells restores the phenotype to that of
normal developing retinas.
Polarized M2 macrophages derived from CD14
1 cells prevent
neovascularization in ischemic retina. The molecular charac-
terization of the rescue effects observed in OIR retinas treated with
CD14
1 cells showed a high degree of myeloid macrophage
differentiation and recruitment of lectin-positive cells. We
hypothesized that polarized activation of macrophages may be the
primarilymediatoroftherescueeffectsintheOIRmodel.Totestthis
hypothesis, we induced the in vitro differentiation of freshly isolated
human UCB-derived CD14
1 cells into activated M1 and M2
macrophages, and each population of activated macrophages was
then injected intravitreally in OIR mice.
IFN-calone,orinconcertwithmicrobialstimuliorcytokines,has
been known to induce differentiation of monocytes into activated
M1
39. M2 is a generic name for various forms of activated macro-
phages, excluding M1 cells but including cells exposed to IL-4 or
IL-13, immune complexes, IL-10, glucocorticoids, or vitamin D3-
derived metabolites
40. M1 macrophages were obtained by in vitro
differentiation of CD14
1 cells using IFN-c, and M2 macrophages
were obtained using IL-4 as previously described
41,42. After 3 days
of in vitro differentiation, we used flow cytometry to assess the level
of pro- and anti-inflammatory cytokines secreted by M1 and M2
subsets. IFN-c-stimulated CD14
1 cells secreted high levels of pro-
inflammatory cytokines IL-8, IL1b and IL-6, whereas IL-4-stimu-
lated CD14
1 cells secreted high levels of anti-inflammatory IL-10
(Supplementary Fig 6).
Three days after in vitro differentiation, M1 and M2 populations
derived from CD14
1 cells were injected intravitreally at P7, and the
mice were maintained in an atmosphere of 75% oxygen for 5 days
(P7–P12) to induce ischemic retinopathy. The areas of vaso-
obliteration measured at P17 were reduced by 75% and 96% in ret-
inas treated with M1 and M2 grafts, respectively, compared to the
vehicle DPBS (Fig 7A, yellow bars). Importantly, only the M2 popu-
lation prevented tuft formation (i.e. neovascularisation) showing a
reduction of 59% of neovascular areas (Fig 7A, red bars). We did not
observe a significant decrease of tuft formation by activated M1
macrophages. Both populations were able to induce rapid resolution
of obliterated areas during the hyperoxic phase, but only the M2
population prevented neovascularization. Thus, the decrease in ret-
inal neovascularization observed in association with reduction of
obliteration is not simply a result of a decrease in the vascularized
area; both M1 and M2 macrophages reduced obliteration, but only
the M2 macrophages also reduced neovascularization. In addition,
only M2 grafts induced a massive recruitment of endogenous
Mannose Receptor-positive cells, a cell shown by others to control
inflammation processes (Fig 7B, C)
43,44.
These data support the concept that this subset of macrophages is
predominantly responsible for the rescue effects of hUCB-derived
CD14
1cells,eitherbyrecruitmentofendogenouspopulationsofM2
macrophages and/or by differentiation of CD14
1 cells in the
ischemic retinas.
Discussion
In this study we demonstrate that hUCB-derived CD14
1 myeloid
progenitor cells, when injected into the ischemic neonatal eye, will
differentiate into macrophage-like cells. The CD14
1 cells, once dif-
ferentiated in mature myeloid cells, recruit and activate endogenous
pro-angiogenic cells that facilitate functional angiogenesis and
reduce inflammation ordinarily observed during OIR. When we
analyzed and compared the transcriptomic profile of CD14
1 and
CD14
2 populations, we observed a different response of the two
fractions to the retinal environment. As freshly isolated cells, the
twopopulationsexhibitdifferentialexpressionformanyofthegenes
analyzed while some of the genes exhibit very similar levels of
expression.
WehavepreviouslydemonstratedthatBM-derivedhematopoietic
progenitor cells injected intravitreally will target activated glia, dif-
ferentiate into endothelial cells and exert trophic rescue activity in
animalmodelsofischemicandneuro-degenerativeretinopathies
45,46.
Injection of BM-derived CD44
hi cells into hypoxic eyes showed that
these cells differentiate into microglia and exert a paracrine-rescue
effect, stabilizing damaged retinal vasculature
26. While heat shock
proteins and chaperones were observed to be upregulated in rescued
retinal neurons, the precise mechanism of rescue remains unclear.
Transcriptomic analysis of CD14
1 cells after injection into OIR ret-
inas shows a selective up-regulation of genes associated with M2-
polarized macrophages.
Our data suggest that the trophic rescue effect of the CD14
1 cells
was associated with their differentiation into M2 cells as well as an
influx of similar cells from the host circulation. Interestingly, four
genes that are expressed at very similar levels between the two cell
populations at day 0, show significantly increased expression in the
CD14
1retinaltransplantincluding,TGFB1,CAT,GUSBandSOD1.
Thesegenesencodeproteinswithmultiplefunctionsincludingregu-
lation of proliferation, differentiation, adhesion, migration and res-
ponse to oxidative stress. For example, SOD1 is expressed at lower
levels in fresh isolated CD14
1 cells compared to CD14
2, but in
CD14
1 transplanted retinas, the expression of this gene was
increased significantly compared to CD14
2 transplanted retinas.
We hypothesized that the CD14
1 fraction can respond to micro-
environmental cues and regulates inflammatory cascades as well as
the response to hypoxia. During the hyperoxic phase of the OIR
model, the CD14
1 cells induce angiogenesis, reducing the area of
vaso-obliteration and associated tissue hypoxia. Vascular regression,
associated with endothelial cell death, is avoided by CD14
1 cell-
induced up-regulation of anti apoptotic and anti-oxidative genes
and associated maintenance of retinal vasculature. Thus, the
CD14
1 cells differentiate into type 2 macrophages, acquiring an
anti-inflammatoryphenotype. Recent studieshaveshown thattissue
macrophages exist as two polarized populations, M1 and M2 sub-
sets
47,48, the former being pro-inflammatory and the latter being
anti-inflammatory. The relative immunological immaturity of the
UCB-derived cells could explain why most monocyte populations
from neonatal blood become M2 polarized cells instead of the pro-
inflammatory M1
29. The M2 cells modulate the inflammatory res-
ponse and facilitate tissue repair
49 enhancing trophic rescue,
enhanced removal of apoptotic cellular debris and inducing tol-
erance rather autoimmunity
50. This idea is further supported by
our observation that after intravitreal injection of CD14
1 cells sti-
mulated to differentiate along M1 or M2 pathways, only the M2
fraction facilitated normalization of the retinal vasculature and
decrease pathological neovascularization.
The concept that macrophages play a critical role during patho-
logicalangiogenesisisstronglysupportedbyrecentwork
20highlight-
ingtheroleofM2mousemacrophages (Angiopoietin receptor1and
Neuropilin1 positive) at the time of brain vascularization. In this
study M2 macrophages interact with endothelial tip cells to promote
vascular anastomosis downstream of VEGF mediated tip cell forma-
tion and sprout induction.
To better understand the molecular events that promote the
trophic rescue effects of the CD14
1 cells in vivo, we also performed
www.nature.com/scientificreports
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analysis on normal retinas, OIR retinas and OIR eyes treated with
CD14
1 cell grafts. A comparison between BALB/cByJ and C57Bl/6J
mouse strains was also performed to identify the metabolic features
associatedwiththe differentbehavioral responsetothe hypoxic con-
ditionscharacteristicoftheOIRmodelinthesetwostrains.Different
oxidized metabolites of cholesterol (oxysterols) were found to be
cytotoxic and induce apoptosis in the retinal vasculature and astro-
cytes. Our results demonstrate that treatment with CD14
1cells con-
trols the deregulation of these metabolites in OIR retinas reducing
their toxicity, protecting photoreceptors, glial components of the
retina and stabilizing the vasculature.
The use of human umbilical cord blood myeloid progenitor cell-
derivedmonocytesandmacrophagesrepresentsapromisingalterna-
tive to adult or embryonic stem cell transplantation for treatment of
ocular diseases. These cells have the capacity to promote physio-
logical angiogenesis and to reduce inflammatory processes assoc-
iated with hypoxic damage in the retina as well as to provide
neurotrophic and anti-apoptotic protection to retinal neurons sub-
jected to ischemic damage. In neonates, UCB would be superior to
Figure 7 | Intravitreal injection of M2 macrophages derived from CD14
1 cells reduces oxygen induced neovascularization. CD14
1 cells were
differentiated into M1 or M2 cells and injected into the vitreous of P7 mice just prior to high oxygen exposure in the OIR model. At P17 the areas of
obliteration (yellow) and neovascular tuft formation (red) were quantified as described in the experimental procedures. Both M1 and M2 populations
significantly reduce the areas of obliteration compared to the control-treated eyes (n517, 15, 10 and 10 respectively, n5number of eyes for each
treatment) (Bonferroni corrected t-test, *P,0.001). M2cells are significantly more effective than the M1cells at reducing the area ofneovascularisation
comparedtothevehicle-ornon-injectedeyes.(B)AtP17,CD14
1-treatedretinasshowrecruitmentofmousemacrophagesexpressingmannosereceptor
(MR) (green). GS-lectin staining shows mouse vasculature (red). (C) MR positive cells are not observed in vehicle-treated eyes (20X).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 1 : 76 | DOI: 10.1038/srep00076 10bone marrow-derived progenitor cells due to the ease of obtaining
cord blood at birth and the biological advantages discussed above.
The potential utility of these cells in treating ischemic retinopathies
suchasretinopathyofprematurityanddiabeticretinopathywarrants
further study.
Methods
AnimalsandOIRmodel.Alltheexperimentswereperformedinaccordancewiththe
NIH Guide for the Care and Use of Laboratory Animals and all experimental
procedures were approved by The Scripps Research Institute Animal Care and Use
Committee. OIR was induced in C57BL/6J mice according to the protocol previously
described
22,23. In some studies BALB/cByJ mice were also subjected to the same
conditions.
Cell preparation and characterization. Human cord blood was obtained from
National Disease Research Interchange (NDRI). Mononuclear cells were isolated
using density gradient centrifugation with Ficoll Paque (Amersham). To isolate the
CD14
1 fraction human Cord Blood Mono Nuclear Cells (CBMNCs) were incubated
with beads attached to anti human CD14 (Miltenyi) and purified according to the
MACS separation system protocol provided by the manufacturer.
InvitroinfectionandlabellingofCD14
1.FreshlyisolatedCD14
1cellsfromhuman
cord blood were incubated for 4–6 hr in M199 medium (Invitrogen) and 20% FBS
with Ad5.F16-GFP at an MOI of5000. After infection the cells werewashed from the
virus and plated overnight. The percentage of GFP-expressing cells was determined
by flow cytometry. For some experiments CD14
1 cells were labelled before injection
with the Dil (Vybrant dye; InVitrogen) according to the manufacturer’s instructions.
Intravitreal injection. Human Cells (250,000/ 0,5 ml) were injected intravitreally
using a 33-gauge needle (Hamilton Co.). In the contralateral eye an equal number/
volume of control cells or vehicle alone was injected in Dulbecco’s PBS.
Staining and quantification of retinal vasculature.. Retinas were harvested and at
various time points for imaging of the vasculature and to localize and characterize
endogenous and injected human cells. Quantification of obliteration and
neovascularization is described in supplemental information.
In Vitro Differentiation of M1 and M2. CD14
1 cells were grown for 4 days in
Myco’s medium plus 10% of FBS and non-essential aminoacids (NEAN). The M1
population was obtained by adding 1000 U/ml human recombinant IFN-c (Sigma).
M2 cells were obtained using 300 U/ml of human recombinant IL-4 (Millipore).
Level of cytokines secreted was measured as described in supplemental information.
Quantitative PCR (QPCR) Gene Expression Analysis. RNA isolation, cDNA
synthesis, and real-time PCR analyses were performed as described in Supplemental
information.
Metabolite extraction and mass spectrometry analysis. Metabolites were extracted
and analyzed by mass spectrometry as previously described
24. However details are
provided in the supplementary information.
Metabolite treatment and Western Blot analysis of cleaved Caspase 3. Mouse
astrocytic (C8D1A), human umbilical vein endothelial (HUVEC) and bovine aortic
endothelial cells (BAEC) were grown until confluent and treated overnight with
different metabolites. Cell death was evaluated by counting the number of trypan
blue positive cells. To test the response to metabolites, C8D1A cells were treated
overnight with 10 mg/ml, 20 mg/ml, or 40 mg/ml of 5,6b-epoxy-, 7-keto-, and
7a-hydroxycholesterol. 1 mM of H2O2 was used as positive control.
For Western Blot analysis, cells and mouse whole retinal lysates were obtained
from normal (NOX) and oxygen treated (OIR) retinas at p12, p15, and p18 using
lysing buffer (1% Triton X-100, Roche protease inhibitor and 1 mM Sigma phenyl-
methanesulphonylfluoride). 30 mg of proteins were loaded in each lane and antibody
to Cleaved Caspase 3 was used (Cell Signaling). Actin levels were used to normalize
the quantity of proteins.
Intravitreal injection of b2epoxy and 7-keto-cholesterol. 0.5 mg and 2 mgo f
7-keto-cholesterol and b-epoxycholesterol, respectively, were injected intravitreally
atp15.After3days,retinasweredissectedandstainedforglialfibrillaryacidicprotein
(GFAP) and GS lectin. Cryosections were obtained from the same retinas and from
OIR P18 retinas treated with vehicle or CD14
1 cells. Images were acquired by
confocal microscopy using a 20X objective lens. DAPI was used to visualize nuclei.
DataAnalysis.Resultsshownaremean6SEM.Asteriskssignsidentifyexperimental
groups that were significantly different from control groups by a t test, one-way
ANOVA, with a Bonferroni correction for multiple comparisons where applicable.
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